Evaluating patient satisfaction with pharmacist-administered long-acting injectable antipsychotics in the community pharmacy

Abstract

Objective: To evaluate patient satisfaction with pharmacist-administered long-acting injectable antipsychotics (LAIAs) in the community pharmacy.

Design: Prospective survey.

Setting: Albertsons Companies community pharmacies during December 2016 to February 2017.

Participants: Patients receiving LAIAs at participating pharmacies.

Main outcome measures: A survey assessed patients' satisfaction with pharmacist-administered LAIAs in the community pharmacy.

Results: LAIA recipients (N = 104) reported satisfaction with community pharmacist-administered LAIAs. Participants who had received the service at other types of health clinics (N = 57) also reported higher satisfaction with current service compared to a similar service received elsewhere. Participants indicated that they would recommend service to others and that service was more convenient than a similar service received in an alternative setting. There was not a statistically significant relationship between patient demographic characteristics and likelihood of recommending service to others.

Conclusion: Patients were satisfied with a pharmacist-administered LAIA service in the community pharmacy, and they found it more convenient than similar services provided elsewhere.